Performance analysis of ImmunityBio (IBRX)
Annual Return
Over the past 3 years, IBRX has had an average annual return of +42.25%, outperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, IBRX has had an average annual return of -6.28%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, IBRX has had an average annual return of +2.33%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Jul 28, 2015, IBRX has had an average annual return of -12.42%, underperforming the benchmark SPY, which returned +14.18% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +307.34% | -22.60% | -49.00% | -1.02% | -16.58% | -54.39% | +251.74% | +226.57% | -74.15% | -21.50% | -67.00% | -49.97% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +215.38% | +56.49% | -21.57% | -7.41% | +5.90% | +16.40% | -7.80% | +307.34% | |||||
| 2025 | +34.78% | -4.62% | -8.53% | -16.57% | +5.93% | -0.78% | -6.82% | -4.79% | +5.03% | -2.39% | -1.73% | -16.01% | -22.60% |
| 2024 | -33.06% | +40.72% | +13.55% | +48.84% | -19.68% | -1.57% | -18.48% | -23.34% | -5.79% | +40.04% | -3.26% | -49.21% | -49.00% |
| 2023 | -25.07% | -35.82% | -25.43% | +53.90% | -1.73% | +1.13% | -20.92% | -26.77% | +4.95% | +85.66% | +17.22% | +36.44% | -1.02% |
| 2022 | -4.27% | +17.56% | -17.97% | -35.31% | +3.53% | -1.01% | +4.56% | +2.85% | +24.24% | +10.66% | +0.19% | -7.98% | -16.58% |
| 2021 | +41.61% | +72.23% | -26.98% | -25.23% | -1.13% | -18.63% | -23.24% | +3.82% | -14.40% | -19.63% | -0.49% | -21.97% | -54.39% |
| 2020 | +66.73% | -23.41% | -40.52% | +35.50% | +72.82% | +82.17% | -8.97% | -34.71% | -4.98% | +8.29% | +27.58% | +39.12% | +251.74% |
| 2019 | -6.87% | +4.49% | +39.88% | -29.17% | -8.05% | -1.01% | +35.37% | -5.78% | -6.13% | -13.92% | +64.03% | +120.12% | +226.57% |
| 2018 | -1.54% | +0.47% | -12.40% | +0.27% | -6.13% | -16.46% | +14.38% | -3.07% | +9.09% | -41.10% | -21.46% | -32.19% | -74.15% |
| 2017 | -6.30% | -11.76% | -24.91% | -11.32% | +16.50% | +106.89% | -14.88% | -3.59% | -12.01% | -15.68% | +6.07% | -8.41% | -21.50% |
Drawdown analysis of ImmunityBio (IBRX)
The maximum drawdown for the IBRX was -97.15%, occurring on Jun 10, 2019. Recovery took 427 trading sessions.
The current IBRX drawdown is -80.90%.
Since Jul 28, 2015 IBRX has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -97.15% | Jul 29, 2015 | 972 | Jun 10, 2019 | 427 | Feb 18, 2021 | 1399 |
| -97.03% | Feb 22, 2021 | 670 | Oct 19, 2023 | Ongoing | Ongoing | Ongoing |